Altera Biosciences is a preclinical‑stage biotechnology company developing a “universal donor” cell platform aimed at off‑the‑shelf allogeneic cell therapies to overcome immune rejection.
Headquarters
Johannesburg 2000
Johannesburg;
Contact Details: Purchase the Altera Biosciences Inc. report to view the information.
Website: https://altera-bio.com/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service